Whalen HR et al. |
High Intrapatient Tacrolimus Variability Is Associated With Worse Outcomes in Renal Transplantation Using a Low-Dose Tacrolimus Immunosuppressive Regime. |
2017 |
Transplantation |
pmid:26950724
|
Lim SW et al. |
Ginseng extract reduces tacrolimus-induced oxidative stress by modulating autophagy in pancreatic beta cells. |
2017 |
Lab. Invest. |
pmid:28759009
|
Saliba F et al. |
Efficacy and Safety of Everolimus and Mycophenolic Acid With Early Tacrolimus Withdrawal After Liver Transplantation: A Multicenter Randomized Trial. |
2017 |
Am. J. Transplant. |
pmid:28133906
|
Alloway RR |
Mounting Clinical Evidence With Tacrolimus Generic Products. |
2017 |
Transplantation |
pmid:28749820
|
de Fijter JW et al. |
Early Conversion From Calcineurin Inhibitor- to Everolimus-Based Therapy Following Kidney Transplantation: Results of the Randomized ELEVATE Trial. |
2017 |
Am. J. Transplant. |
pmid:28027625
|
Willerth SM |
Localized Tacrolimus Delivery Repairs the Damaged Central Nervous System. |
2017 |
EBioMedicine |
pmid:29195745
|
Savaj S et al. |
Irreversible Lesions of Tacrolimus-induced Posterior Reversible Leukoencephalopathy Syndrome. |
2017 |
Iran J Kidney Dis |
pmid:29190599
|
Kabat-Koperska J et al. |
Birth defects in juvenile Wistar rats after exposure to immunosuppressive drugs during pregnancy. |
2017 |
Histol. Histopathol. |
pmid:27097725
|
Ma X et al. |
Inhibition effect of tacrolimus and platelet-derived growth factor-BB on restenosis after vascular intimal injury. |
2017 |
Biomed. Pharmacother. |
pmid:28633129
|
Zidan AS |
Taste-masked tacrolimus-phospholipid nanodispersions: dissolution enhancement, taste masking and reduced gastric complications. |
2017 |
Pharm Dev Technol |
pmid:26811031
|
Weir MR et al. |
Long-term Follow-up of Kidney Transplant Recipients in the Spare-the-Nephron-Trial. |
2017 |
Transplantation |
pmid:26950714
|
Ueno P et al. |
Wound Healing Complications in Kidney Transplant Recipients Receiving Everolimus. |
2017 |
Transplantation |
pmid:27490418
|
Berntsen HF et al. |
The fungal neurotoxin penitrem A induces the production of reactive oxygen species in human neutrophils at submicromolar concentrations. |
2017 |
Toxicology |
pmid:29037868
|
Gu K et al. |
Atypical pneumonia due to human bocavirus in an immunocompromised patient. |
2017 |
CMAJ |
pmid:28507089
|
Nakamura Y et al. |
Successful Treatment of Behçet's Disease Associated with Acute Myeloid Leukemia with Myelodysplasia-related Changes Using Azacitidine and Tacrolimus before Allogeneic Hematopoietic Stem Cell Transplantation. |
2017 |
Intern. Med. |
pmid:28502936
|
Jouve T et al. |
New formulations of tacrolimus and prevention of acute and chronic rejections in adult kidney-transplant recipients. |
2017 |
Expert Opin Drug Saf |
pmid:28494654
|
Kim YJ et al. |
Two cases of hydroa vacciniforme-like lymphoproliferative disease controlled by anti-inflammatory agents. |
2017 |
Photodermatol Photoimmunol Photomed |
pmid:28543883
|
Zong YP et al. |
Effects of CYP3A5 polymorphisms on tacrolimus pharmacokinetics in pediatric kidney transplantation: a systematic review and meta-analysis of observational studies. |
2017 |
World J Pediatr |
pmid:28540692
|
Seo SR et al. |
Disrupted Skin Barrier is Associated with Burning Sensation after Topical Tacrolimus Application in Atopic Dermatitis. |
2017 |
Acta Derm. Venereol. |
pmid:28512670
|
Wolfshohl JA et al. |
Improvement of erythema dyschromicum perstans using a combination of the 1,550-nm erbium-doped fractionated laser and topical tacrolimus ointment. |
2017 |
Lasers Surg Med |
pmid:27552666
|
Sanghavi K et al. |
Genotype-guided tacrolimus dosing in African-American kidney transplant recipients. |
2017 |
Pharmacogenomics J. |
pmid:26667830
|
Undre N and Dickinson J |
Relative bioavailability of single doses of prolonged-release tacrolimus administered as a suspension, orally or via a nasogastric tube, compared with intact capsules: a phase 1 study in healthy participants. |
2017 |
BMJ Open |
pmid:28377389
|
Størset E et al. |
Response to: 'Response to: Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance'. |
2017 |
Br J Clin Pharmacol |
pmid:28374426
|
Vanhove T et al. |
Effect of ABCB1 diplotype on tacrolimus disposition in renal recipients depends on CYP3A5 and CYP3A4 genotype. |
2017 |
Pharmacogenomics J. |
pmid:27378609
|
Ericzon BG et al. |
Pharmacokinetics of prolonged-release tacrolimus versus immediate-release tacrolimus in de novo liver transplantation: A randomized phase III substudy. |
2017 |
Clin Transplant |
pmid:28295581
|
Lawrance IC et al. |
Efficacy of Rectal Tacrolimus for Induction Therapy in Patients With Resistant Ulcerative Proctitis. |
2017 |
Clin. Gastroenterol. Hepatol. |
pmid:28286194
|
Ikeda K et al. |
Intestinal perforation due to hemorrhagic Cytomegalovirus enteritis in a patient with severe uncontrolled lupus nephritis: a case and review of the literature. |
2017 |
Rheumatol. Int. |
pmid:28283734
|
Morita M et al. |
The onset risk of carcinoma in patients continuing tacrolimus topical treatment for oral lichen planus: a case report. |
2017 |
Odontology |
pmid:27368962
|
Smolders EJ et al. |
Decreased tacrolimus plasma concentrations during HCV therapy: a drug-drug interaction or is there an alternative explanation? |
2017 |
Int. J. Antimicrob. Agents |
pmid:28185946
|
Shimizu S et al. |
Reduction of FR900525 using an S-(2-aminoethyl) l-cysteine-resistant mutant. |
2017 |
J. Biosci. Bioeng. |
pmid:28185832
|
Hashemizadeh Z et al. |
Observational Study of Associations between Voriconazole Therapeutic Drug Monitoring, Toxicity, and Outcome in Liver Transplant Patients. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28923870
|
Nishiya Y et al. |
A new efficient method of generating photoaffinity beads for drug target identification. |
2017 |
Bioorg. Med. Chem. Lett. |
pmid:28108248
|
Hamada T et al. |
Phenotypic analysis of circulating T-cell subset and its association with burden of skin disease in patients with chronic actinic dermatitis: a hematologic and clinicopathologic study of 20 subjects. |
2017 |
Int. J. Dermatol. |
pmid:28176301
|
Chung BH et al. |
Suppressive Effect of 1α,25-Dihydroxyvitamin D3 on Th17-Immune Responses in Kidney Transplant Recipients With Tacrolimus-Based Immunosuppression. |
2017 |
Transplantation |
pmid:28107277
|
Wungwattana M and Savic M |
Tacrolimus interaction with nafcillin resulting in significant decreases in tacrolimus concentrations: A case report. |
2017 |
Transpl Infect Dis |
pmid:28067989
|
Ak K et al. |
Tacrolimus-Eluting Suture Inhibits Neointimal Hyperplasia: An Experimental In Vivo Study in Rats. |
2017 |
Eur J Vasc Endovasc Surg |
pmid:28065442
|
Ma TK et al. |
Therapeutic drug monitoring of once-daily tacrolimus (Advagraf) in a gastrectomized kidney transplant recipient. |
2017 |
Nephrology (Carlton) |
pmid:28064453
|
MartÃn-Fernández M et al. |
Effects of Cyclosporine, Tacrolimus, and Rapamycin on Osteoblasts. |
2017 |
Transplant. Proc. |
pmid:29149986
|
Ivulich S et al. |
Clinical Challenges of Tacrolimus for Maintenance Immunosuppression Post-Lung Transplantation. |
2017 |
Transplant. Proc. |
pmid:29149976
|
Obaidat RM et al. |
Using Supercritical Fluid Technology (SFT) in Preparation of Tacrolimus Solid Dispersions. |
2017 |
AAPS PharmSciTech |
pmid:27116202
|
Nakamura K et al. |
AS2553627, a novel JAK inhibitor, prevents chronic rejection in rat cardiac allografts. |
2017 |
Eur. J. Pharmacol. |
pmid:27993641
|
Khan SA et al. |
Improvement in baroreflex control of renal sympathetic nerve activity in obese Sprague Dawley rats following immunosuppression. |
2017 |
Acta Physiol (Oxf) |
pmid:28456134
|
Gelens MACJ et al. |
No evidence for progressive deterioration in stimulated insulin secretion in renal transplant recipients after 12years tacrolimus exposure. |
2017 |
J. Diabetes Complicat. |
pmid:28720321
|
Wan T et al. |
Dual roles of TPGS based microemulsion for tacrolimus: Enhancing the percutaneous delivery and anti-psoriatic efficacy. |
2017 |
Int J Pharm |
pmid:28629978
|
Tremblay S and Alloway RR |
Clinical Evaluation of Modified Release and Immediate Release Tacrolimus Formulations. |
2017 |
AAPS J |
pmid:28717926
|
Ganschow R et al. |
Everolimus and reduced calcineurin inhibitor therapy in pediatric liver transplant recipients: Results from a multicenter, prospective study. |
2017 |
Pediatr Transplant |
pmid:28714558
|
Soiffer RJ et al. |
Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation. |
2017 |
J. Clin. Oncol. |
pmid:29040031
|
Hasegawa J et al. |
Preemptive anti-cytomegalovirus therapy in high-risk (donor-positive, recipient-negative cytomegalovirus serostatus) kidney transplant recipients. |
2017 |
Int. J. Infect. Dis. |
pmid:28986314
|
Chen P et al. |
Dynamic effects of CYP3A5 polymorphism on dose requirement and trough concentration of tacrolimus in renal transplant recipients. |
2017 |
J Clin Pharm Ther |
pmid:27885697
|
Grinyó JM et al. |
Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase 2 Randomized Trial. |
2017 |
Am. J. Kidney Dis. |
pmid:27889299
|